Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inovio Pharma (NQ: INO )

1.660 -0.020 (-1.19%)
Streaming Delayed Price Updated: 1:19 PM EST, Jan 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,412,111
Open 1.680
Bid (Size) 1.660 (62)
Ask (Size) 1.670 (145)
Prev. Close 1.680
Today's Range 1.640 - 1.700
52wk Range 1.380 - 4.280
Shares Outstanding 210,356,896
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
If You Invested $1,000 In Inovio Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now
Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two and a half years. But there was no question some big-name stocks performed... 
Via Benzinga
Futu Holdings, UP Fintech Holding And Some Other Big Stocks Moving Lower On Friday
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Friday. Here are some big stocks recording losses in today’s session. 
Via Benzinga

Performance

YTD
+9.21%
+9.21%
1 Month
+6.41%
+6.41%
3 Month
-23.15%
-23.15%
6 Month
-13.09%
-13.09%
1 Year
-59.81%
-59.81%

More News

Read More
Micron, Lexicon Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket
Via Benzinga
Inovio Pharmaceuticals (INO) Q3 2022 Earnings Call Transcript
Via The Motley Fool
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket
Via Benzinga
Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious Disease Programs
Via Benzinga
3 Stocks to Avoid Right Now
Via The Motley Fool
While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants
Via FinancialNewsMedia
Exposures COVID-19
Why Inovio Pharmaceuticals Stock Is Popping Off
Via Benzinga
What's Going On With Inovio Pharmaceuticals Stock Tuesday After Hours
Via Benzinga
Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa
Via Benzinga
Why Inovio Pharmaceuticals Stock Zoomed Nearly 6% Higher Today
Via The Motley Fool
Inovio Pharma Stops Work On INO-4800 As COVID-19 Heterologous Booster
Via Benzinga
Why Inovio Pharmaceuticals' Shares Jumped 17.31% on Monday
Via The Motley Fool
Inovio Pharma Highlights Early Data From Experimental Drug For Respiratory Tract Disease
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Via Benzinga
Philips, Owens & Minor And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
Via Benzinga
Tesla, Credit Suisse And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed
Via Benzinga
Recap: Inovio Pharmaceuticals Q2 Earnings
Via Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
Via Benzinga
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
Via Benzinga
Two Appealing Biotech Stocks for Two Distinct investors
Via MarketBeat
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.